We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

KemPharm Post Positive Results From Phase 1 Trial

News   Jan 11, 2017 | Original Story From KemPharm

 
KemPharm Post Positive Results From Phase 1 Trial
 
 
 

RELATED ARTICLES

Nanotechnology Approach for Treating Aggressive Breast Cancer

News

Triple negative breast cancer has no currently approved targeted therapies for treatment. Utilizing nanotechnology, a research group have developed a method that targets specific genes in triple negative breast cancer, killing cancerous cells.

READ MORE

Hidden Differences Between CTE and Alzheimer's Identified

News

There has been a long-held hypothesis stating that chronic traumatic encephalopathy and Alzheimer’s disease tau tangles were made in the same way. However, a study utilizing cryo-electron microscopy has revealed a very different picture.

READ MORE

Drug Designed to Treat Opioid Cravings Begins Clinical Trial Testing

News

Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE